NIH-funded research NIH-funded research

How DNA-protein cross-links form and are repaired

Official title: Formation and Repair Mechanisms of DNA-Protein Cross-Links, and Functions and Regulatory Mechanisms of TREX1 in DNA Repair

Funded at University of Texas at Austin · NIH-11122279 · Data updated 2026-11-12

This study is looking at how certain harmful links between DNA and proteins form and how our cells can fix them, which is important for understanding cancer and improving treatments, especially for patients undergoing chemotherapy.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Texas at Austin
NIH-funded
Lab location1 site (Austin, United States)
Project startJuly 1, 2024
Project endMay 31, 2029
Funding year2025
Award (this year)$383,760
NIH project number5R35GM155148-02
Project IDNIH-11122279 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients undergoing chemotherapy or those with conditions related to DNA damage and repair mechanisms.

Less likely to help

Patients with conditions unrelated to DNA damage or those not undergoing cancer treatment may not benefit from this research.

What this research studies

This research investigates the mechanisms behind the formation and repair of DNA-protein cross-links, which are harmful DNA lesions that can lead to genome instability and diseases, including cancer. The study focuses on understanding how these cross-links occur, particularly in relation to single-strand breaks in DNA, and how they can be repaired. By utilizing advanced techniques like mass spectrometry, the research aims to quantify these lesions and explore their implications for cellular health and response to chemotherapy. Patients may benefit from insights gained into how to enhance the effectiveness of cancer treatments and reduce side effects.

Why it matters

Potential benefit: If successful, this research could lead to improved cancer treatment strategies by identifying new biomarkers and enhancing the efficacy of existing therapies.

How similar studies have gone: Previous research has shown promise in understanding DNA damage and repair mechanisms, suggesting that this approach could yield valuable insights.

Where this research is happening

  • University of Texas at Austin
    Austin, United States
    Active

Researchers

  • Principal investigator: Yang, Kun — University of Texas at Austin
  • Study coordinator: Yang, Kun

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.